Fatty acid synthase (FAS) is a recently discovered molecule involved in the energy supply to normal cells. FAS is overexpressed in neoplastic tissues because of their increased energy needs. We explored the immunohistochemical expression of FAS, Ki-67 and p53 in squamous cell carcinomas (SCC) of the larynx and their association with clinicopathological features and outcome. Specimens from 43 patients with SCC were evaluated. Statistical analysis revealed an association between poorly differentiated laryngeal carcinomas and FAS expression (p0.005) and between FAS and Ki-67 overexpression (p0.001). Finally, FAS expression was associated with overall survival (p0.001). We suggest that FAS is a powerful prognostic indicator whose strength can be enhanced when it is evaluated together with clinicopathological data and Ki-67 expression.
Immunohistochemical expression of fatty acid synthase, Ki-67 and p53 in squamous cell carcinomas of the larynx / DE VINCENTIIS, Marco; DI CELLO, P; Censi, F; Leopizzi, Martina; Natalizi, S; Sardella, B; Gallo, Andrea; Soldo, Pietro; Alò, Pl; Zotti, Gc; DELLA ROCCA, Carlo; Castelli, M; Izzo, L.; Pietrasanta, Dario. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 23(3):(2008), pp. 176-181.
Immunohistochemical expression of fatty acid synthase, Ki-67 and p53 in squamous cell carcinomas of the larynx
DE VINCENTIIS, Marco;LEOPIZZI, MARTINA;GALLO, Andrea;SOLDO, Pietro;DELLA ROCCA, Carlo;IZZO L.;PIETRASANTA, DARIO
2008
Abstract
Fatty acid synthase (FAS) is a recently discovered molecule involved in the energy supply to normal cells. FAS is overexpressed in neoplastic tissues because of their increased energy needs. We explored the immunohistochemical expression of FAS, Ki-67 and p53 in squamous cell carcinomas (SCC) of the larynx and their association with clinicopathological features and outcome. Specimens from 43 patients with SCC were evaluated. Statistical analysis revealed an association between poorly differentiated laryngeal carcinomas and FAS expression (p0.005) and between FAS and Ki-67 overexpression (p0.001). Finally, FAS expression was associated with overall survival (p0.001). We suggest that FAS is a powerful prognostic indicator whose strength can be enhanced when it is evaluated together with clinicopathological data and Ki-67 expression.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.